CNE1000070M8
CNE1000070M8
SUNSHINE PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.815.065.000 | 4.018.905.000 | 19.8% |
| Cost of Revenue | 1.129.670.000 | 960.274.000 | 17.6% |
| Gross Profit | 3.685.395.000 | 3.058.631.000 | 20.5% |
| 3.054.344.000 | 2.574.035.000 | 18.7% | |
| Operating Income | 631.051.000 | 484.596.000 | 30.2% |
| Pretax Income | 439.564.000 | 141.054.000 | 211.6% |
| Net Income Common Stockholders | 272.442.000 | -207.434.000 | 231.3% |
| -- | -- | -- | |
| -- | -- | -- |